Data Governance for Computer Systems Regulated by FDA

In this webinar attendees will learn about FDA’s regulatory expectations for classifying, assessing the risk, testing, and validating a computer system used in FDA-regulated work. Also attendees will learn in detail about the System Development Life Cycle (SDLC) methodology used to approach Computer System Validation (CSV), including all of the phases, sequencing of events, deliverables, and documentation requirements.

WHY SHOULD YOU ATTEND?

The FDA governs the computer systems used to collect, analyze, transfer and report data that is in support of FDA regulated activities required for drug development and approval. FDA oversight is based on a Predicate Rule, known as “Good Practices,” or simply, “GxPs.”

Computer systems subject to GxP requirements must be thoroughly and appropriately validated in accordance with FDA’s guidance on computer system validation. This involves a rigorous set of phases and steps to ensure that, in the language of FDA, “a system does what it purports to do.”

The cost of adequately validating a GxP computer system can be high, and must be weighed against system risk and usage. GAMP 5 system classification guidelines can help ensure that a GxP system is categorized appropriately, based on the type of system and technology involved. Along with risk, system classification can provide a clear-cut pathway for validating a system, based on the appropriate level of testing and validation effort.

All types of data management and information systems will be discussed, including those based on in-house developed code, configurable systems and custom designed systems. Best industry practices and potential pitfalls in validating laboratory systems, along with examples, will be covered in detail.

Ongoing maintenance of the system in a validated state will be discussed, as well as governance, archival and retirement. These functions are critical to maintaining data in a state of integrity. We will also cover the establishment of a Data Governance Committee, the Charter, roles and responsibilities, and oversight. Such a committee is critical to successfully maintaining control over GxP systems and governing the state of integrity of the data housed in them.

We will also discuss the importance of applying good project management, business process re-engineering and organizational change management principles through the validation process and beyond.

AREA COVERED

• Data Integrity
• Data Governance
• FDA GxPs (GMPs, GLPs, GCPs, GDPs)
• Computer System Validation (CSV) Methodology
• System Development Life Cycle (SDLC) Framework
• Risk Management
• GAMP 5
• Compliance Strategy
• Cost vs. Compliance
• Industry Best Practices
• Policies and Procedures
• Training
• Leveraging Vendors

LEARNING OBJECTIVES

Upon completing this course participants should:

• Understand FDA requirements for Computer System Validation (CSV)
• Understand the System Development Life Cycle (SDLC) approach to validation
• Utilize GAMP 5 system classification and risk methodologies for categorizing systems and developing a validation pathway
• Understand how to build a complete validation strategy and program for GxP systems
• Know how to manage the validation process and create FDA-compliant documentation
• Know how to monitor a GxP system that is in production, governing the data and system through retirement
• Understand the roles and responsibilities required to validate a system and maintain it in a validated state in order to assure data integrity
• Know how to measure cost vs. compliance risk for a GxP system
• Understand good project management principles, incorporating business process re-engineering and organizational change management into the process
• Know the policies and procedures that must be developed and maintained to support the GxP system in operation, and the data you are governing
• Understand how to leverage the vendor and other external resources to apply the best industry practices and avoid potential pitfalls when validating a GxP system
• Know about FDA trends in oversight and audit of GxP systems and how to keep abreast of these

WHO WILL BENEFIT?

This webinar is intended for those working in the FDA-regulated industries, including pharmaceutical, medical device, biotechnology, and tobacco. Functions that are applicable include research and development, clinical sample manufacturing, packaging, labeling, Quality testing, distribution, clinical testing and management, adverse events management and post-marketing surveillance.

You should attend this webinar if you are responsible for planning, executing or managing the implementation of any GxP system governed by FDA regulations, or if you are maintaining or supporting such a system. Examples of who will benefit from this webinar include:

• Data “Owners”
• Data “Stewards”
• Information Technology Analysts
• Information Technology Developers and Testers
• QC/QA Managers and Analysts
• Clinical Data Managers and Scientists
• Analytical Chemists
• Compliance and Audit Managers
• Laboratory Managers
• Automation Analysts
• Computer System Validation Specialists
• GMP Training Specialists
• GLP Training Specialists
• Business Stakeholders/Subject Matter Experts
• Business System/Application Testers

This webinar will also benefit any consultants working in the life sciences industry who are involved in computer system implementation, validation and compliance.